Are Brooks Lab. latest results good or bad?

Brooks Laboratories has reported notable financial results for the quarter ending June 2025, indicating a significant turnaround in its profitability. The company achieved a Profit Before Tax (PBT) of Rs 9.36 crore, which represents a substantial growth compared to the average PBT of the previous four quarters, where it was at Rs -2.68 crore. Similarly, the Profit After Tax (PAT) reached Rs 9.58 crore, reflecting a considerable increase from the average PAT of Rs -2.49 crore in prior quarters.
Net sales for Brooks Laboratories reached Rs 25.51 crore, marking a growth of 23.6% over the previous four-quarter average of Rs 20.64 crore. The operating profit also showed a positive trend, reaching Rs 3.12 crore, which is the highest recorded in the last five quarters, with an operating profit margin of 12.23%, suggesting enhanced operational efficiency.

Earnings per share (EPS) rose to Rs 3.25, the highest in five quarters, indicating improved profitability. Overall, the financial metrics suggest a positive operational trend for Brooks Laboratories in the near term.

Additionally, there was an adjustment in the company’s evaluation, reflecting the changes in its financial performance. The quarterly results show a net sales growth of 9.39% compared to the previous quarter, while the consolidated net profit exhibited a remarkable growth of 756.16%. The operating profit margin also improved, indicating a favorable operational environment for the company.